K. Bottom

Most-cited papers

1. Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience.

   C. Turner, S. Gururangan, J. Eastwood, K. Bottom +7 more

   200283 citations Open access

   Semantic Scholar

   Save

2. Gliomatosis cerebri: cytologic and autopsy findings in a case involving the entire neuraxis.

   Thomas J. Cummings, C. Hulette, D. Longee, K. Bottom +2 more

   1999Clinical Neuropathology31 citations

   Semantic Scholar

   Save

3. Phase II study of carboplatin (CBDCA) in progressive low-grade gliomas.

   Albert Moghrabi, Henry S. Friedman, D. M. Ashley, K. Bottom +17 more

   1998Neurosurgical Focus21 citations Open access

   Semantic Scholar

   Save

4. Evaluation of Pre-radiotherapy Cyclophosphamide in Patients with Newly Diagnosed Glioblastoma Multiforme

   K. Bottom, D. Ashley, H. Friedman, D. Longee +9 more

   2004Journal of Neuro-Oncology9 citations

   Semantic Scholar

   Save

5. Crystal-storing histiocytosis and extranodal marginal zone lymphoma of the lung in a child with common variable immunodeficiency

   K. Kelemen, M. V. Burgesser, K. Bottom, K. Leslie

   2013Journal of Hematopathology3 citations Open access

   Semantic Scholar

   Save

6. Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience.

   Christopher D. Turner, S. Gururangan, J. Eastwood, K. Bottom +7 more

   2002Neuro-Oncology1 citations Open access

   Semantic Scholar

   Save

7. Phase II study of irinotecan ( CPT-11 ) in children with high-risk malignant brain tumors : The Duke experience 1

   C. Turner, S. Gururangan, J. Eastwood, K. Bottom +7 more

   20050 citations

   Semantic Scholar

   Save